Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Read-Gene SA should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Read-Gene SA for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Read-Gene SA
13.64%
0.35
43.54%
Poland WIG
39.24%
1.84
20.48%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
15.58%
EBIT Growth (5y)
15.97%
EBIT to Interest (avg)
-0.33
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.44
Tax Ratio
4.14%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.16%
ROE (avg)
1.48%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
7.91
EV to EBITDA
7.91
EV to Capital Employed
0.82
EV to Sales
0.60
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
1.24%
ROE (Latest)
1.55%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend16What is working for the Company
OPERATING CASH FLOW(Y)
Highest at PLN 5.11 MM
NET SALES(HY)
At PLN 6.99 MM has Grown at 37.3%
ROCE(HY)
Highest at -9.22%
RAW MATERIAL COST(Y)
Fallen by -145.36% (YoY
CASH AND EQV(HY)
Highest at PLN 14.61 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -20.2 %
INVENTORY TURNOVER RATIO(HY)
Highest at 3,138.6%
PRE-TAX PROFIT(Q)
At PLN 0.2 MM has Grown at 174.52%
NET PROFIT(Q)
At PLN 0.2 MM has Grown at 173.62%
-4What is not working for the Company
INTEREST(HY)
At PLN 0 MM has Grown at 4,236.8%
Here's what is working for Read-Gene SA
Net Sales
At PLN 6.99 MM has Grown at 37.3%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (PLN MM)
Operating Cash Flow
Highest at PLN 5.11 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (PLN MM)
Pre-Tax Profit
At PLN 0.2 MM has Grown at 174.52%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (PLN MM)
Net Profit
At PLN 0.2 MM has Grown at 173.62%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (PLN MM)
Cash and Eqv
Highest at PLN 14.61 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at -20.2 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 3,138.6%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -145.36% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Read-Gene SA
Interest
At PLN 0 MM has Grown at 4,236.8%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (PLN MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
